California Cannabis: Past Criminal Conviction Not a Deal Breaker Under Proposed Rules Amendments

On October 16, 2020, the Bureau of Cannabis Control (“BCC”) issued a Notice of Proposed Rulemaking relating to regulatory changes to the commercial cannabis license application process. The proposed rule changes will affect Title 16, California Code of Regulations, sections 5002, 5017, 5021 and 5600.

These proposed regulations will implement the statutory changes called for in AB 2138, which was signed by the Governor on September 30, 2018. The provisions within AB 2138 became operative on July 1, 2020, and were intended to remove some of the licensing and employment barriers faced by those with prior criminal convictions or disciplinary actions where those individuals can demonstrate rehabilitation. According to the BCC’s press release:

[T]he changes to the statutes prohibit bureaus from requiring applicants for licensure to disclose information or documentation regarding the applicant’s criminal history. Additionally, if a bureau decides to deny an applicant for licensure, the bureau must provide the applicant with notice of the denial, including the reason for the denial, as well as instructions for appealing the decision and the process for receiving a copy of the applicant’s conviction history.

AB 2138 also amends BPC section 480 to prohibit a bureau from denying a

Read More Here...

What Are The Most Abundant Cannabinoids?

Everyone fascinated by the science behind cannabis is familiar with two of the most common cannabinoids: THC and CBD.

However, did you know that the cannabis plant can produce at least 144 cannabinoids?
While research on the properties of all 144 of these compounds is not yet available, credible information does exist for all of the most abundant cannabinoids.

Cannabinoids 101
First, it’s critical that we define what a cannabinoid is: Cannabinoids are compounds present not only in cannabis, but also in all human (and mammalian) bodies.

When referring to cannabinoids present in cannabis itself, the term “phytocannabinoid” is used. Phytocannabinoids are found in the sticky resin glands (trichomes) on cannabis plants.

– Read the entire article at Benzinga.

Read More Here...

COVID-19 Pandemic a ‘Boon’ for Legal Cannabis in Canada as Marijuana Industry Turns Two

Canada’s legal marijuana industry is celebrating a jump in sales, more brick-and-mortar stores and competitive pricing as it celebrates two years in business.

Since Canada legalized recreational marijuana on Oct. 17, 2018, legal sellers and producers have struggled to compete with the black market, but there have been recent gains in the licensed industry.

The change? The coronavirus pandemic, says retail marketing expert David Soberman.

– Read the entire article at Global News.

Read More Here...

Montana Cannabis Legalization Guide (Initiative 190 and CI-118)

This November 2020 election, cannabis legalization initiatives will appear on the ballots of five states: Arizona, Mississippi, Montana, New Jersey and South Dakota. Every Sunday until November 3, Canna Law Blog will publish a post centered on one of these state ballot initiatives, and the current laws surrounding cannabis in that state. Today is the third post, in which we discuss the two measures concerning cannabis that will be on the Montana ballot this November: Initiative 190, known as the Marijuana Legalization and Tax Initiative (2020), and CI-118, or the Allow for a Legal Age for Marijuana Amendment (2020).

What are the current laws surrounding cannabis in Montana?

Recreational cannabis is illegal in Montana. However, in 2004 Montanans voted to legalize cannabis for medical use, with 62 percent of voters in approval of the Medical Marjuana Allowance Act. The Medical Marijuana Allowance Act allowed patients with painful and debilitating conditions to produce and use cannabis.

Despite the large majority of Montana voters who voted in favor of the Medical Marijuana Allowance Act, the State legislature has since attempted to dismantle and limit the law. In 2011, the Montana State House of Representatives voted to repeal the law, but the

Read More Here...

How One Man’s Psychedelic Journey May Change the Face of Schizophrenia Treatment

CANNABIS CULTURE – “It is well understood that people with schizophrenia should not take large dosages of psychedelics because it is destabilizing,” says Mark Haden, Executive Director of the Multidisciplinary Association for Psychedelic Studies (MAPS) in Canada.  “But we don’t know the effect of small dosages and how that can impact them.”

The future of psychosis treatment took a new turn when Haden met a young man named “John Doe,” who had experience in microdosing for his psychosis.   Several years ago, Doe had reached out to MAPS looking to tell a fascinating story.  The email made its way to Haden, and the two decided to meet for lunch.  Doe began to tell Haden about his harrowing journey, discussing his extensive battle with schizophrenia throughout his teens and young adult life, the extreme anguish of dealing with negative voices in his head every day, and the failure of traditional medications and intoxicants to improve his symptoms.  

Doe told Haden, “Everything was always my fault, and the blame was always 100% on me. I was seriously flawed, and the voices pointed this out to me all day. I had no way to escape them, and they were getting stronger and darker.”  But

Read More Here...

What Bill Weinberg Misunderstands About Hemp Ethanol

CANNABIS CULTURE – “Now that hemp has finally arrived at its long-sought status as a legal crop and commodity, to what extent will it deviate from the utopian vision that animated the advocates who fought for it a generation ago?”

– Bill Weinberg, HEMP: FROM MYTHOS TO MONOCULTURE, August 27th, 2020

Bill Weinberg is a long-time cannabis activist and a hero of mine. He wrote for such periodicals as High Times and Overthrow beginning in the 1980s, and performs a selfless service maintaining such websites as, which is a review of geopolitics from a left-wing perspective, and, a one-man cannabis information project. 

Bill always does great work, and I rarely disagree with him on things (our differences are mainly limited to conspiracy vs. coincidence theories or whether left wingers are evil/fatally flawed or just ignorant about some topics) but he really screwed up his last evaluation on hemp ethanol – so much so it inspired me to write a rebuttal. 

Bill wrote an article for Project CBD entitled: “HEMP: FROM MYTHOS TO MONOCULTURE – The Curious Cultural Trajectory of Industrial Cannabis”

and then reposted the article on his Global Ganja Report website.

Bill made five major

Read More Here...

Hemp Litigation: DEA Sued Again

The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register:

Most recently, Nathalie Bougenies wrote about a petition for review against the DEA filed by the Hemp Industries Association and RE Botanicals in the United States Court of Appeals for the District of Columbia (the “D.C. Circuit”). Why the fuss? As Nathalie explained, the IFR:

suggests that in-process hemp shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. ‘Any point’ includes even fleetingly during the processing phase and includes situations where the THC percentage is brought back into legal compliance for the finished product.

So will the DEA start raiding hemp processors? Who knows, but the implications are not good and led to the hemp industry making a concerted effort against the IFR. One such effort is the petition for review, which contends the IFR is unlawful because it exceeds the DEA’s authority, violates the Agricultural Improvement Act of 2018, and contends that the DEA violated the regulations governing the promulgation of rules set

Read More Here...

DOJ's Antifa Push Spurs Trump Appointee To Charge A Band's Bassist Over A Bag Of Weed

A top federal prosecutor appointed by President Donald Trump held a news conference this week to announce that the “outstanding investigative work” of federal and state law enforcement officers had resulted in a federal felony charge against a 29-year-old bassist in an anarcho-punk band over a bag of weed.

Justin Coffman and his friends and family in Jackson, Tennessee, think that U.S. Attorney D. Michael Dunavant, a Trump appointee, is trying to make an example out of a Trump opponent. Coffman joined Black Lives Matter protests, belonged to a rock band with an anarchist theme and posted memes poking fun at what he saw as Republicans’ overblown concerns about the loosely organized anti-fascist movement known as “antifa.”

The law enforcement investigation into Coffman began in the days after George Floyd’s death on May 25. Coffman, like millions of Americans, was outraged that Minneapolis police had choked the life out of the 46-year-old Black man.

“It broke his heart,” Leah Harris, Coffman’s girlfriend,

Read More Here...

“Pain Can Affect Everything.” Sports Columnist Documents His Success Treating Chronic Nerve Pain With Medical Cannabis

Jeff Seidel exhausted just about every therapy available before turning to cannabis as a last resort.

When Detroit Free Press sports columnist Jeff Seidel noticed a sharp pain between his shoulder blade and spine, he thought he might have overexerted himself at the gym. Or maybe it was old injuries rearing up again.

What Seidel didn’t expect was that the pain would progress and worsen, and seemingly be unaffected by conventional therapies. Eventually, he decided to try something he’d avoided his entire life.

– Read the entire article at Regina Leader-Post.

Read More Here...

France Gives Final Go-Ahead For Medical Cannabis Testing Program

If the testing programme turns out to be a success, France could become the 23rd European country allowing medical use of cannabis.

For two years, 3,000 patients in France will be able too legally use cannabis as treatment for their illnesses.

Set to last for a period of two years, the testing programme “authorises experimentation with the therapeutic use of cannabis in a controlled and limited setting with patients suffering from serious illnesses,” according to the government’s website.

– Read the entire article at The Local.

Read More Here...